Navigation Links
Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
Date:12/19/2011

CAMBRIDGE, Mass., Dec. 19, 2011 /PRNewswire/ -- Metamark Genetics, Inc. announced today that it has entered into a research, collaboration, and license agreement with Janssen Biotech, Inc.  The agreement is based on Metamark's discovery platform for the identification and characterization of specific proprietary cancer targets demonstrated to play a causal role in promoting tumor progression and spread (Prognosis Determinants™). The collaboration will focus on the evaluation and validation of several of Metamark's Prognosis Determinants. Upon selection of the targets, Janssen Biotech will receive a limited exclusive license under Metamark's intellectual property and know-how and will thereafter be responsible for the discovery, development, and commercialization of therapeutic inhibitors targeting the specific Prognosis Determinants.

 "We are delighted to enter into this important alliance with Janssen Biotech," said Eric Devroe, Ph.D., Vice President of Business & Strategy Development at Metamark. "This collaboration and license agreement reflects the value of Metamark's innovative approach to identifying genes and proteins that drive aggressive behavior of tumors – both in the development of prognostic assays as well as in supporting the discovery and development of novel targeted therapeutics."

Metamark will receive an initial upfront payment from Janssen Biotech as well as near-term milestone payments following initial target validation. Under the terms of the agreement, Metamark may be eligible to receive up to $365 million in milestone payments across multiple targets, based upon the achievement of specified development, regulatory, and commercialization goals. In addition, Metamark will be entitled to royalties on worldwide net sales of therapeutics and any associated companion diagnostics upon commercialization.

Commenting on the agreement, Metamark President and CEO, Mark R. Straley, stated, "Our ulti
'/>"/>

SOURCE Metamark Genetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Metamark Genetics, Inc. Announces New Chief Scientific Officer
2. Metamark Genetics, Inc. Announces New Chief Executive Officer
3. Metamark and HistoRx Announce Licensing Agreement for AQUA® Technology
4. Interleukin Genetics Licenses its PST(R) Genetic Test to OralDNA Labs
5. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
6. Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests
7. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
8. Exosome Diagnostics Appoints Johan Skog, Ph.D., as Director of Genetics Research
9. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
10. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2008 Financial Results
11. Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/4b8vj2/injectable_drug ) has announced the addition of ... Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables ... Free & Auto Injectors] & Therapeutics [Diabetes ... report to their offering. ...
(Date:6/18/2013)... Though health care jobs continued to be added ... Labor Statistics -- the increase was far below the calendar ... care jobs were added in home health care and outpatient ... jobs. Overall, the U.S. unemployment rate stayed flat at 7.6 ... that a total of just over 36,000 job cuts were ...
(Date:6/18/2013)... Port Monmouth, NJ (PRWEB) June 18, 2013 ... for the AdWords advertising platform. As this directly impacts ... this to be the one of the most sweeping updates ... at Core and More Technologies recently posted a very ... not initially set a ‘must-have’ upgrade date for enhanced ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Kitware ... today announces a new Fast-Track award from the U.S. ... design-analysis environment (IDAE) for the nuclear power industry. , ... for more than 30 years, but the United States’ ... remarkable gains in power plant utilization through improved refueling, ...
Breaking Biology Technology:Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3Core and More Technologies Helps Organizations Migrate to Google’s Enhanced Campaign Structure 2Core and More Technologies Helps Organizations Migrate to Google’s Enhanced Campaign Structure 3Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2
... Jan. 23, 2012 Novus International Inc., a leading ... and Verenium Corporation (Nasdaq: VRNM ), a ... commercialization of high-performance enzymes, today announced the selection of ... the two companies, strategic collaboration to advance ...
...   NeoStem, Inc. (NYSE Amex: NBS ) ... focus on cell-based therapeutic development, today announced that its Chief ... 2 clinical trial for AMR-001 for preservation of heart ... of its subsidiary, Progenitor Cell Therapy, LLC , have ...
... Jan. 23, 2012   BioLife Solutions , Inc. (OTCBB: ... hypothermic storage and cryopreservation freeze ... three additional key opinion leaders in the biobanking ... markets have joined the Company,s Scientific Advisory ...
Cached Biology Technology:First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration 2First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration 3First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration 4First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration 5Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease 2Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease 3Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease 4BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board 2BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board 3BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board 4BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board 5
(Date:6/17/2013)... JOLLA, CA June 17, 2013 An international ... (TSRI), the Howard Hughes Medical Institute and Albert Einstein ... highly promising new anti-tuberculosis compound that attacks the tuberculosis ... represent an effort to help solve one of the ... TB and its dangerous drug-resistant strains," said Peter G. ...
(Date:6/17/2013)... 17, 2013 As mobile devices, smartphones ... secure them grows exponentially, and biometric authentication offers ... Heavy Reading Insider ( www.heavyreading.com/mobile-networks ), ... ( www.heavyreading.com ). Biometrics Offer ... for biometric authentication on smartphones, analyzing the most ...
(Date:6/17/2013)... and Entrepreneurship will be the topics under discussion ... June. For the third consecutive year, this will ... sharing of experiences among members of Academy, Business, ... students. Confirmed speakers: Elisa Martn Garijo (IBM South ... Tree) and Mary O,Donovan (Hovione), among others. E3 ...
Breaking Biology News(10 mins):New compound excels at killing persistent and drug-resistant tuberculosis 2New compound excels at killing persistent and drug-resistant tuberculosis 3New compound excels at killing persistent and drug-resistant tuberculosis 4Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3'E3 Forum -- Education, Employment & Entrepreneurship on a Global context' 2
... functions is largely based on our family,s genetic makeup, according ... published in the international publication the Journal of Neuroscience ... how ,cost-efficient, our brain network wiring is, shedding light on ... Alex Fornito from the Melbourne Neuropsychiatry Centre at the University ...
... the important first rung of the food web each spring ... to its advantage, according to the first published findings about ... algae as a kind of antifreeze against temperatures well below ... channels and pores in ice that are hospitable to itself ...
... bugs, originally from Asia, were first detected in Pennsylvania ... and vegetables and invading homes in many parts of ... entomologists from the eastern U.S. and Canada will converge ... brown marmorated stink bug plague during the 82nd Annual ...
Cached Biology News:Better brain wiring linked to family genes 2Algal antifreeze makes inroads into ice 2Stink bug experts gather in Pennsylvania to address growing problem 2
Rabbit polyclonal to Staphylococcus Enterotoxin A (HRP) ( Abpromise for all tested applications)....
... Novexin offers bespoke, cost-effective solutions for complex protein processing ... expertise and experience to help you develop a solution ... , ... transfer all methodology to ...
... is a highly scalable analysis platform ... in a workgroup or an enterprise ... 40 leading pharmaceutical, biotechnology, academic and ... streamlines genomics research at large and ...
... LC Sciences provides a genome-wide microRNA ... and proprietary probe design, which enable highly ... (1-3). We have standard arrays for mature ... latest version of the Sanger miRBase database ...
Biology Products: